The importance of on-treatment biopsies was demonstrated in ICI studies in MM, where CD8 TIL density after pembrolizumab [28] and fold-increase in TIL infiltration after ipilimumab, but not at baseline, was associated with objective responses [29]. Here, CD8A is linked to Miyoshi myopathy.